Muscular Atrophy, Spinal, Type Ii: Disease Bioinformatics
Spinal Muscular Atrophy Type II is the weakening of the voluntary muscles in the arms and legs. The protein that is essential to the motor neurons in the spinal cord deteriorates and dies causing immobility in the legs and arms. The symptoms of Spinal Muscular Atrophy Type II include difficulty walking and frequent falls. Spinal Muscular Atrophy Type II begins between 6 to 18 months old and generally impairs the legs more than the arms. The later Spinal Muscular Atrophy Type II begins, the better the prognosis. Children affected by the disease are expected to live to adolescence or young adulthood. There is no treatment for Spinal Muscular Atrophy Type II, but research continues.
Muscular Atrophy, Spinal, Type Ii Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Muscular Atrophy, Spinal, Type Ii below!
For more information on how to use Laverne, please read the How to Guide.
We have 407 products for the study of Muscular Atrophy, Spinal, Type Ii that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.